Drug intelligence / Profile preview

BM19

Development stage
Preclinical
Lead developer
Jagiellonian University
Modality
Small Molecules
01

Overview

BM19 is a novel piperazine arylideneimidazolone derivative, specifically characterized as a biphenylmethylene derivative, that functions as an efflux pump inhibitor and biofilm inhibitor [P2660]. Developed by researchers at Jagiellonian University and Wroclaw Medical University, BM19 is designed to target multidrug-resistant (MDR) *Helicobacter pylori* strains [P2660]. It acts as an adjuvant to potentiate the activity of standard antibiotics, such as metronidazole and clarithromycin, by inhibiting the HefA component of the Resistance-Nodulation-Division (RND) efflux system [P2660]. This inhibition leads to increased intracellular accumulation of antibiotics and significantly suppresses biofilm formation, offering a promising strategy to overcome antibiotic resistance in *Helicobacter pylori* eradication therapies [P2660].

Other names
biphenylmethylene derivative BM19
02

Targets

HefA (Outer membrane protein of the HefABC efflux system HefA)

Beyond the preview

Go deeper on BM19.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BM19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call